Medicare Enrolled
Dr. Eihab Akary, MD
Urology Physician · Modesto, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Akary from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Akary?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Akary
Dr. Eihab Akary is an urology physician in Modesto, CA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Akary performed 3,880 Medicare services across 2,454 unique beneficiaries.
Between the years covered by Open Payments, Dr. Akary received a total of $4,301 from 27 pharmaceutical and/or device companies across 112 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Akary is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 22% volume in CA
$4,301 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,880
Medicare services
Top 22% in CA for urology physician
2,454
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~353 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
680 | $95 | $236 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
499 | $64 | $145 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
403 | $96 | $209 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
392 | $140 | $393 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
359 | $8 | $25 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
288 | $2 | $7 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
162 | $0 | $13 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
146 | $128 | $317 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 138 | $137 | $657 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
111 | $171 | $424 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
105 | $10 | $29 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
87 | $72 | $169 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
61 | $41 | $101 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
52 | $20 | $53 |
| Simple change of bladder tube | 48 | $71 | $174 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
45 | $106 | $259 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
44 | $41 | $100 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
29 | $96 | $431 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
29 | $25 | $67 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
27 | $11 | $33 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
26 | $449 | $1,374 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
21 | $106 | $434 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
21 | $90 | $222 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
20 | $273 | $920 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
20 | $520 | $1,520 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
18 | $48 | $127 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
18 | $158 | $420 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
16 | $44 | $179 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
15 | $26 | $445 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
17.6% medium
81.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,301
Total received (2018-2024)
Avg $614/year across 7 years
Top 37% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
112
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,121 (95.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$180 (4.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$167
2023
$949
2022
$1,539
2021
$359
2020
$312
2019
$665
2018
$309
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Endo Pharmaceuticals Inc.
$44
Boston Scientific Corporation
$30
PFIZER INC.
$29
Teleflex LLC
$23
Becton, Dickinson and Company
$22
Sumitomo Pharma America, Inc.
$18
Top 3 companies account for 61.9% of 2024 payments
All-time payments by company (2018-2024) ›
Teleflex LLC
$1,536
Endo Pharmaceuticals Inc.
$561
Coloplast Corp
$549
Boston Scientific Corporation
$266
COLOPLAST CORP
$196
NeoTract Inc.
$189
Dornier MedTech America, Inc
$167
Medtronic USA, Inc.
$123
Janssen Biotech, Inc.
$92
Astellas Pharma US Inc
$82
Allergan, Inc.
$71
PFIZER INC.
$58
Merck Sharp & Dohme LLC
$54
180 Medical, Inc.
$53
Antares Pharma, Inc.
$44
Supernus Pharmaceuticals, Inc.
$41
Allergan Inc.
$35
Profound Medical Corp.
$24
Becton, Dickinson and Company
$22
AbbVie Inc.
$22
Blue Earth Diagnostics Limited
$21
Sumitomo Pharma America, Inc.
$18
ABBVIE INC.
$18
Axonics, Inc.
$17
Calyxo, Inc.
$15
Tolmar, Inc.
$14
Laborie Medical Technologies Corp.
$14
Top 3 companies account for 61.5% of all-time payments
Associated products mentioned in payments ›
ARISTA AH FlexiTip · AVEED · Axonics · BOTOX · CONTINENCE CARE · CVAC ASPIRATION SYSTEM · Dornier MedTech · EDEX · ELIGARD · ERECTILE DYSFUNCTION · ERLEADA · Erleada · GentleCath · INTERSTIM · KEYTRUDA · LYNPARZA · Myrbetriq · ORGOVYX · OTREXUP · Otrexup · POSLUMA · Rezum Generator · SCOPE · SPEEDICATH · SUPRIS · SpeediCath · Superion Indirect Decompression System · TITAN · Titan · Tulsa-Pro · UROLIFT · UroLift · UroLift System · XIAFLEX · XTANDI · XYOSTED
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
18
Per 100K population
3.3
County median income
$79,661
Nearest hospital
DOCTORS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Akary is a clinical cardiology specialist, with above-average Medicare volume (top 22% in CA), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Akary experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Akary performed 680 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Akary receive payments from pharmaceutical companies?
Yes. Dr. Akary received a total of $4,301 from 27 companies across 112 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Akary's costs compare to other urology physicians in Modesto?
Dr. Akary's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Akary) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Modesto
Browse urology physicians in Modesto ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Endo Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Endo Pharmaceuticals Inc.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology